Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veerle Lejon

Showing results (21-30 of 92) with videos related to

Pageof 10
Sort By:
The Journal of Infectious Diseases|June 17, 2015
Trypanosoma brucei gambiense Spliced Leader RNA Is a More Specific Marker for Cure of Human African Trypanosomiasis Than T. b. gambiense DNAHamidou Ilboudo, Oumou Camara, Sophie Ravel, et al.
Plos Neglected Tropical Diseases|June 23, 2011
Identification of peptide mimotopes of Trypanosoma brucei gambiense variant surface glycoproteinsLiesbeth Carolien Van Nieuwenhove, Stijn Rogé, Fatima Balharbi, et al.
Tropical Medicine & International Health : TM & IH|April 23, 2014
Immune trypanolysis test with blood spotted on filter paper for epidemiological surveillance of sleeping sicknessOumou Camara, Mamadou Camara, Veerle Lejon, et al.
Veterinary Parasitology|October 2, 2003
Performance of enzyme-linked immunosorbent assays for detection of antibodies against T. congolense and T. vivax in goatsVeerle Lejon, Dierk E Rebeski, Momar Ndao, et al.
The Journal of Infectious Diseases|April 30, 2003
Intrathecal immune response pattern for improved diagnosis of central nervous system involvement in trypanosomiasisVeerle Lejon, Hansotto Reiber, Dominique Legros, et al.
The Journal of Infectious Diseases|January 6, 2007
Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sicknessSylvie Bisser, François-Xavier N'Siesi, Veerle Lejon, et al.
Clinical and Vaccine Immunology : CVI|April 13, 2007
Treatment failure related to intrathecal immunoglobulin M (IgM) synthesis, cerebrospinal fluid IgM, and interleukin-10 in patients with hemolymphatic-stage sleeping sicknessVeerle Lejon, Jo Robays, François Xavier N'Siesi, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
Targets of the human antibody response to the variant surface glycoprotein of <i>Trypanosoma brucei</i>Jaime So, Bailin Zhang, Lulu Singer, et al.
Plos One|August 23, 2013
External quality assessment of reading and interpretation of malaria rapid diagnostic tests among 1849 end-users in the Democratic Republic of the Congo through Short Message Service (SMS)Pierre Mukadi, Philippe Gillet, Albert Lukuka, et al.
Plos Neglected Tropical Diseases|March 3, 2011
Diagnostic accuracy of PCR in gambiense sleeping sickness diagnosis, staging and post-treatment follow-up: a 2-year longitudinal studyStijn Deborggraeve, Veerle Lejon, Rosine Ali Ekangu, et al.
Pageof 10

Showing results (21-30 of 92) with videos related to

Sort By:
Pageof 10
The Journal of Infectious Diseases|June 17, 2015
Trypanosoma brucei gambiense Spliced Leader RNA Is a More Specific Marker for Cure of Human African Trypanosomiasis Than T. b. gambiense DNAHamidou Ilboudo, Oumou Camara, Sophie Ravel, et al.
Plos Neglected Tropical Diseases|June 23, 2011
Identification of peptide mimotopes of Trypanosoma brucei gambiense variant surface glycoproteinsLiesbeth Carolien Van Nieuwenhove, Stijn Rogé, Fatima Balharbi, et al.
Tropical Medicine & International Health : TM & IH|April 23, 2014
Immune trypanolysis test with blood spotted on filter paper for epidemiological surveillance of sleeping sicknessOumou Camara, Mamadou Camara, Veerle Lejon, et al.
Veterinary Parasitology|October 2, 2003
Performance of enzyme-linked immunosorbent assays for detection of antibodies against T. congolense and T. vivax in goatsVeerle Lejon, Dierk E Rebeski, Momar Ndao, et al.
The Journal of Infectious Diseases|April 30, 2003
Intrathecal immune response pattern for improved diagnosis of central nervous system involvement in trypanosomiasisVeerle Lejon, Hansotto Reiber, Dominique Legros, et al.
The Journal of Infectious Diseases|January 6, 2007
Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sicknessSylvie Bisser, François-Xavier N'Siesi, Veerle Lejon, et al.
Clinical and Vaccine Immunology : CVI|April 13, 2007
Treatment failure related to intrathecal immunoglobulin M (IgM) synthesis, cerebrospinal fluid IgM, and interleukin-10 in patients with hemolymphatic-stage sleeping sicknessVeerle Lejon, Jo Robays, François Xavier N'Siesi, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
Targets of the human antibody response to the variant surface glycoprotein of <i>Trypanosoma brucei</i>Jaime So, Bailin Zhang, Lulu Singer, et al.
Plos One|August 23, 2013
External quality assessment of reading and interpretation of malaria rapid diagnostic tests among 1849 end-users in the Democratic Republic of the Congo through Short Message Service (SMS)Pierre Mukadi, Philippe Gillet, Albert Lukuka, et al.
Plos Neglected Tropical Diseases|March 3, 2011
Diagnostic accuracy of PCR in gambiense sleeping sickness diagnosis, staging and post-treatment follow-up: a 2-year longitudinal studyStijn Deborggraeve, Veerle Lejon, Rosine Ali Ekangu, et al.
Pageof 10